Amgen (AMGN) Other Non-Current Assets (2009 - 2026)

Amgen has reported Other Non-Current Assets for 18 years, with the latest figure at $13.0 billion in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 17.75% year-over-year to $13.0 billion in Q2 2026; TTM through Jun 2026 was $13.0 billion, a 17.75% increase from a year earlier, with the FY2025 full-year figure at $12.7 billion, up 27.49% from the prior year.
• Other Non-Current Assets was $13.0 billion for Q2 2026 at Amgen, up from $12.8 billion in the prior quarter.
• The five-year high for Other Non-Current Assets was $13.2 billion in Q3 2025, with the low at $5.9 billion in Q4 2022.
• Average Other Non-Current Assets over 5 years is $9.4 billion, with a median of $9.3 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets retreated 9.58% in 2022, then surged 62.93% in 2023.
• Over 5 years, Other Non-Current Assets stood at $5.9 billion in 2022, then soared by 62.93% to $9.6 billion in 2023, then climbed by 3.32% to $9.9 billion in 2024, then climbed by 27.49% to $12.7 billion in 2025, then rose by 2.5% to $13.0 billion in 2026.
• The last three Other Non-Current Assets figures came in at $13.0 billion (Q2 2026), $12.8 billion (Q1 2026), and $12.7 billion (Q4 2025), per Business Quant data.